The Cochrane Database of Systematic Reviews 2005
|
Sign up to set email alerts
Diacerein for osteoarthritis
Search citation statements
Order By: Relevance
Paper Sections
Select...
16
4
4
1
Citation Types
0
19
0
3
Year Published
Range
2007
20072021
2021Publication Types
Select...
23
1
Relationship
0
24
Authors
Journals
Cited by 24 publications
(22 citation statements)
References 14 publications
0
19
0
3
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] . The present study used 50 mg and 100 mg in the experimental design because previous human studies reported that the effective dose of diacerein was between 50-150 mg per day [13,19] . However, because the weights of all animals in this study were not more than 25 kg, we limited the dosage to 50 and 100 mg per day, while in human studies the highest dose was 150 mg for an average body weight of 60 kg.…”
Section: Discussion
mentioning
confidence: 83%
“…Previous in vitro studies have reported that diacerein inhibits the secretion of IL-1β in a dose-dependent manner [9,19] . But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] .…”
Section: Discussion
mentioning
confidence: 98%
“…In humans, the main side effects that have been reported are diarrhea/soft stools and dark urine [19] . Our study is the first to report on the side effects of diacerein in dogs.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] . The present study used 50 mg and 100 mg in the experimental design because previous human studies reported that the effective dose of diacerein was between 50-150 mg per day [13,19] . However, because the weights of all animals in this study were not more than 25 kg, we limited the dosage to 50 and 100 mg per day, while in human studies the highest dose was 150 mg for an average body weight of 60 kg.…”
Section: Discussion
mentioning
confidence: 83%
“…Previous in vitro studies have reported that diacerein inhibits the secretion of IL-1β in a dose-dependent manner [9,19] . But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] .…”
Section: Discussion
mentioning
confidence: 98%
“…In humans, the main side effects that have been reported are diarrhea/soft stools and dark urine [19] . Our study is the first to report on the side effects of diacerein in dogs.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…An additional review described the heterogeneity (I 2 = 71%, P = 0.06) but ignored it due to "lack of stability of the known tests" [ 29 ], which is not a valid reason for ignoring heterogeneity. In another review, the authors divided the analysis into subgroups because they had found heterogeneity, but although the consequence was that the chi-square test for heterogeneity was no longer significant due to loss of power, the I 2 actually increased , which the authors failed to comment on [ 30 ]. In yet another review, which was discussed above, the authors pooled two risk scores measured on different scales that varied by a factor of ten [ 11 ].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…4 65 With these guidelines, the effect of the weight loss may be achieved within a few months, resulting in a clinical ES larger than most non-operative treatments systematically reviewed, applying meta-analyses, [66][67][68][69] and at least comparable to the possible effect of walking. 70 In the present meta-analysis, it is obvious that the strategies applied in the individual RCTs combine great diversity in both magnitude and intensity of the (weight-reducing) dietary strategies.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] . The present study used 50 mg and 100 mg in the experimental design because previous human studies reported that the effective dose of diacerein was between 50-150 mg per day [13,19] . However, because the weights of all animals in this study were not more than 25 kg, we limited the dosage to 50 and 100 mg per day, while in human studies the highest dose was 150 mg for an average body weight of 60 kg.…”
Section: Discussion
mentioning
confidence: 83%
“…Previous in vitro studies have reported that diacerein inhibits the secretion of IL-1β in a dose-dependent manner [9,19] . But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] .…”
Section: Discussion
mentioning
confidence: 98%
“…In humans, the main side effects that have been reported are diarrhea/soft stools and dark urine [19] . Our study is the first to report on the side effects of diacerein in dogs.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…An additional review described the heterogeneity (I 2 = 71%, P = 0.06) but ignored it due to "lack of stability of the known tests" [ 29 ], which is not a valid reason for ignoring heterogeneity. In another review, the authors divided the analysis into subgroups because they had found heterogeneity, but although the consequence was that the chi-square test for heterogeneity was no longer significant due to loss of power, the I 2 actually increased , which the authors failed to comment on [ 30 ]. In yet another review, which was discussed above, the authors pooled two risk scores measured on different scales that varied by a factor of ten [ 11 ].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…4 65 With these guidelines, the effect of the weight loss may be achieved within a few months, resulting in a clinical ES larger than most non-operative treatments systematically reviewed, applying meta-analyses, [66][67][68][69] and at least comparable to the possible effect of walking. 70 In the present meta-analysis, it is obvious that the strategies applied in the individual RCTs combine great diversity in both magnitude and intensity of the (weight-reducing) dietary strategies.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] . The present study used 50 mg and 100 mg in the experimental design because previous human studies reported that the effective dose of diacerein was between 50-150 mg per day [13,19] . However, because the weights of all animals in this study were not more than 25 kg, we limited the dosage to 50 and 100 mg per day, while in human studies the highest dose was 150 mg for an average body weight of 60 kg.…”
Section: Discussion
mentioning
confidence: 83%
“…Previous in vitro studies have reported that diacerein inhibits the secretion of IL-1β in a dose-dependent manner [9,19] . But in clinical usage, there was no significant difference between 50 and 150 mg per day for pain score and clinical signs of OA [19] .…”
Section: Discussion
mentioning
confidence: 98%
“…In humans, the main side effects that have been reported are diarrhea/soft stools and dark urine [19] . Our study is the first to report on the side effects of diacerein in dogs.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…An additional review described the heterogeneity (I 2 = 71%, P = 0.06) but ignored it due to "lack of stability of the known tests" [ 29 ], which is not a valid reason for ignoring heterogeneity. In another review, the authors divided the analysis into subgroups because they had found heterogeneity, but although the consequence was that the chi-square test for heterogeneity was no longer significant due to loss of power, the I 2 actually increased , which the authors failed to comment on [ 30 ]. In yet another review, which was discussed above, the authors pooled two risk scores measured on different scales that varied by a factor of ten [ 11 ].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…4 65 With these guidelines, the effect of the weight loss may be achieved within a few months, resulting in a clinical ES larger than most non-operative treatments systematically reviewed, applying meta-analyses, [66][67][68][69] and at least comparable to the possible effect of walking. 70 In the present meta-analysis, it is obvious that the strategies applied in the individual RCTs combine great diversity in both magnitude and intensity of the (weight-reducing) dietary strategies.…”
Section: Discussion
mentioning
confidence: 99%